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Abstract 
 
Mucosal Associated Invariant T (MAIT) cells are restricted by the monomorphic MHC class I-like 
molecule, MHC-related protein-1 (MR1). Until 2014, the identity of the potent activating MAIT cell 
ligands was unknown, although it was established that MAIT cells could be activated by a broad 
range of bacteria and yeasts, possibly suggesting a conserved antigen. Using a combination of 
protein chemistry, mass spectrometry, structural biology and chemistry, we discovered MAIT cell 
antigens derived from folic acid (vitamin B9) and from an intermediate in the microbial biosynthesis 
of riboflavin (vitamin B2). While the folate derivative 6-formyl pterin (6-FP) generally inhibited 
MAIT cell activation, two riboflavin pathway derivatives, 5-(2-oxopropylideneamino)-6-D-
ribitylaminouracil (5-OP-RU) and 5-(2-oxoethylideneamino)-6-D-ribitylaminouracil (5-OE-RU), 
were very potent MAIT cell agonists. Other intermediates and derivatives of riboflavin synthesis 
displayed only weak or no MAIT cell activation. Collectively, these studies revealed that in addition 
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to peptide and lipid-based antigens, small molecule natural product metabolites are also ligands that 
can activate T cells expressing ab T cell receptors, and here we recount this discovery. 
 
Introduction 
 
Mucosal associated invariant T (MAIT) cells first came to attention because of their semi-invariant 
TCR a-chain rearrangement observed by Porcelli et al. 1. A rearrangement of the TRAV1-2 element 
juxtaposed to TRAJ33 was enriched among the CD4-CD8- (double negative, DN) T cell population in 
healthy blood donors 1. Less frequent usage of TRAJ12 and TRAJ20 segments in combination with 
TRAV1-2 are also present in MAIT cells 2-5. Homologous versions were found in DN T cells in mice, 
cows 6 and sheep 7. The Va-Ja rearrangement did allow for two variable amino acids encoded at the 
V-J junction. In addition, the repertoire of TCR b-chains paired with the semi-invariant a-chain was 
skewed 1, 6, being dominated by TRBV6 and TRBV20 in humans and the murine orthologous 
segments of TRBV6 in mice 6. Notably, this oligoclonality of MAIT TCR b-chains noted by Tilloy et 
al. 6 was later confirmed 4, who also observed a bias in the length of 11 to 14 amino acids. 
 
The limited TCR repertoire of MAIT cells suggested that they might be restricted by a 
monomorphic, non-classical major histocompatibility complex (MHC) molecule 1. Lantz’s team 
proposed the MHC class I-like molecule, MHC-related protein-1 (MR1) 8, 9, as a candidate 6 and later 
formally demonstrated MR1 as the selective and restrictive element 10. MR1 is monomorphic 9, 11 and 
represents the most highly conserved MHC-I like gene across diverse mammalian species, with 90% 
sequence identity between mouse and humans as compared to 70% for classical MHC-I genes in the 
ligand binding site 8, 9, 12. Perhaps, it is not surprising therefore, that MR1 selects a restricted TCR 
repertoire. Lantz’s team furthermore showed that while MR1 is present in most mammals, including 
marsupials, it is absent from several clades of eutherians (e.g. cat, dog, panda, ferret, rabbit, pika, and 
armadillo) 12. Species featuring MR1 also have a TRAV1 a-chain, with a high inter-species 
conservation of the CDR1 and CDR2 regions 12 and associated cross-reactivity between certain 
species such as human, non-human primates, bovine, rat and mouse 13-16, indicating the phylogenetic 
conservation of this T cell subset in mammals and suggesting an important physiological function.  
 
Treiner et al. observed preferential location of MAIT cells at mucosal sites such as the gut lamina 
propria (and to a lesser extend the lung) of humans and mice. Hence, Lantz’s team named the T cell 
subset mucosal-associated invariant T (MAIT) cells 10. Recent studies also showed MAIT cells to be 
present at non-mucosal sites (e.g. liver) 17, 18 and they appear to be widely distributed among tissues 
and somewhat more prevalent in the lung than the gut (e.g. in C57BL/6 mice 19, 20). This tendency for 
mature MAIT cells to take up widespread tissue residency, including mucosal localisation, as well as 
circulating in the blood where they can represent a high percentage of T cells in humans, suggests 
the moniker of MAIT cells adds to the famously confusing jargon of immunology.  
 
Le Bourhis et al. and Gold et al. later demonstrated that a wide variety of microbes (bacteria, yeasts) 
(Table 1), but not viruses cause MR1-restricted MAIT cell responses. The bacterial response was 
dependent on the interaction between the MAIT TCR and an unknown antigen (Ag) presented by 
MR1, presumably either derived from bacteria or a bacteria-induced endogenous Ag 2, 21. Following 
these important studies, Lantz’s team speculated that ‘this ligand could be of multiple compositions, 
but the MR1-invariant TCR interaction would be non-discriminative, or it could be an extremely 
conserved compound among microbes’ 21; the latter mirroring the finding of a single universal Ag for 
type I NKT cells 2. 
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Based on sequence comparisons by Miley et al. and a structure-based computation analysis by 
Hansen et al., it was suggested that MR1 adopted an ‘MHC-I fold’ 22, 23. Indeed, it was known that 
MR1 associates with b2-microglobulin (b2m) 23, 24, further implying MR1 possessed an MHC-I-like 
structure. Whilst lipid-based Ags had been proposed to bind to MR1 25, 26, the residues lining the 
putative ligand binding groove were noted to be markedly different from either MHC-I or CD1d 22, 23 
suggesting that MR1 did not bind peptide or glycolipid Ags. This observation led to the idea that 
MR1 ‘may bind a unique ligand with an anchoring scheme unlike that of other MHC class Ia or class 
Ib proteins’ 22. 
 
The nature of the Ag(s) that activated MAIT cells was a major stumbling block in the field of MAIT 
cell biology. We considered that an understanding of the Ag(s) recognised by MAIT cells would 
help unlock the biology of these cells. In 2009, more than 15 years after the discovery of MAIT cells, 
our laboratories embarked on the challenge of identifying MAIT cell-stimulating MR1-bound Ag(s). 
This question was addressed by a multidisciplinary and highly collaborative approach that utilised a 
combination of methodologies, including protein chemistry, mass spectrometry, cellular biology, 
structural biology and chemistry. This review recounts the discoveries of vitamin B-related 
compounds that modulate MAIT cell function.   
 
 
Main body  
 
Establishment of experimental models providing key insights into the nature of MR1 bound 
antigens 
 
As a first step in identifying MR1 ligands that activate MAIT cells, it was key to establish a reliable 
experimental model to assess MR1-dependent MAIT cell activation. For this purpose, genes 
encoding MAIT TCR a- and b-chains were introduced into a Jurkat T cell line (Jurkat.MAIT). These 
expressed the MAIT TCR very well and stained with a Va7.2 mAb 27.  
 
Jurkat.MAIT cells upregulated CD69 when co-incubated with bacterially infected C1R cells 
expressing endogenous levels of MR1. Jurkat.MAIT cell activation was augmented when C1R cells 
were supertransfected with the MR1 gene and overexpressed MR1 at the cell surface. Jurkat.MAIT 
cell activity could be blocked by the MR1 specific monoclonal antibody 26.5 28, verifying MR1 
dependency of the observed activity. As an ongoing source of Ag(s), the bacterium Salmonella 
enterica serovar Typhimurium (S. Typhimurium) was investigated. S. Typhimurium infected C1R 
cells led to activation of Jurkat.MAIT cells in the co-culture assay. An advance was the discovery 
that culture supernatant of S. Typhimurium passed through a 0.2 µm filter also activated the 
Jurkat.MAIT cell line in an MR1-dependent manner. The fact that the infection of an Ag presenting 
cell (APC) was not required for the presentation of MR1 bound Ag(s), was important as it meant that 
the Ag(s) of interest were likely to be secreted or shed in vitro and hence they were probably soluble. 
This key observation suggested that biochemically homogeneous and potentially soluble Ag(s) could 
be recovered from bacterial supernatant rather than working with highly complex bacterial lysates 
where the solubility of the Ag(s) was unknown.  
 
Given the apparent solubility of the MR1 ligands in bacterial supernatant, we opted to identify their 
chemical nature via biochemical/mass spectrometry approaches. MHC and MHC-I like proteins are 
generally stable only in the presence of a given Ag, and thus we reasoned that the ability to 
sufficiently fold MR1 would only be possible in the presence of an MR1 ligand. Using Garboczi’s 
original protocol of MHC-I folding 29, we found that filtered supernatant from S. Typhimurium could 
sponsor in vitro folding of denatured, soluble MR1, expressed in Escherichia coli, in the presence of 
Commented [II1]: Perhaps we could insert after 
“discoveries” : 
 
“, made by a team of immunologists, structural biologists and 
chemists from three interacting laboratories, 
2018 ICB Special Feature Review – MAIT cells 
b2m (Figure 1). Intriguingly, we noticed that for some samples of MR1, folded in the presence of S. 
Typhimurium supernatant, the tip of the tube was slightly yellow. 
 
An important control at this point was to test if RPMI medium, used to culture S. Typhimurium prior 
to harvesting the supernatant, also supported folding of MR1. Surprisingly, small amounts of MR1 
did fold in the presence of straight RPMI medium. This finding suggested that RPMI medium also 
potentially furnished a ligand that could bind to MR1. The native conformation of MR1 folded in the 
presence of S. Typhimurium culture supernatant or RPMI was confirmed by its ability to bind to the 
monoclonal antibody 26.5 in an enzyme linked immunosorbent assay (ELISA). The size exclusion 
chromatography retention time was almost overlapping with classical MHC molecules bound to 
peptide. Moreover, the stoichiometry with associated b2m was 1:1 based on SDS-PAGE, exactly as 
observed for classical MHC molecules and b2m 30. Based on these insights, we considered that mass 
spectrometry of folded MR1 might be a suitable approach to identify the nature of the ligands 
captured by MR1 for presentation to MAIT cells. 
 
 
Discovery of MR1 ligands that act as competitive inhibitors of MAIT cell activation  
 
Given that RPMI medium contains defined components and supported folding of small amounts of 
MR1 in the absence of bacterial culture, we initially turned to this source of material to identify 
MR1-captured ligands. Among the components in RPMI are flavonoid-derived vitamins, which are 
yellow in colour. Thus, MR1 was folded in the presence of a solution of vitamin B tablets obtained 
from a local pharmacy. Indeed, we recovered native MR1 from this folding experiment. When we 
then tested individual vitamin components in MR1 folding experiments, we observed that folic acid 
(vitamin B9) yielded significant amounts of native MR1. MR1 folded in the presence of folic acid or 
RPMI medium was then analysed by mass spectrometry, in collaboration with the laboratories of 
Purcell, McConville and O'Hair. In negative ion mode, this analysis revealed two mass-to-charge 
(m/z) species of 190.03 and 147.03 that were absent in analyses of control blank and classical 
peptide-MHC-I samples. Puzzlingly, the m/z 440.13 expected for folic acid (C19H19N7O6) by mass 
spectrometry, was not detected in material captured by MR1 even in the presence of folic acid. A 
search of the Scripps Metlin data bank revealed that the two identified species matched fragments of 
biopterin, which shares a pterin moiety with folic acid. It was known that folic acid photodegrades in 
ultraviolet light to 6-formyl pterin (6-FP, C7H5N5O2, m/z 190.04) and p-aminobenzoyl-L-glutamic acid 
(C12H14N2O5, m/z 265.08) 31 (Figure 2a). Subsequent collision-induced dissociation (CID) fragmentation 
of 6-FP revealed that the m/z 147.03 species was a product ion of the parent m/z 190.03 species. 
MR1 was previously observed to be expressed at low levels on the surface of cells under basal 
conditions 32. Notably, 6-FP upregulated MR1 surface expression, reminiscent of the rescue of 
surface expression of MHC-I in cells deficient in peptide transporter (tap-2) 33. This observation 
suggested that 6-FP was a bona fide MR1 ligand. We learnt recently that degradation of folic acid to 
6-FP also occurs in vivo, in skin exposed to UV radiation 34. 
 
That 6-FP was bound to MR1 was consistent with the ability to fold MR1 in the presence of pure 6-
FP purchased from Schircks Laboratories. The purified product was indistinguishable from MR1 
folded with folic acid, based on chromatography profiles (e.g. retention time), SDS-PAGE of 
purified MR1, and identical m/z 190.03 species. What was unknown however was the molecular 
mechanism by which MR1 captured 6-FP.  Was 6-FP merely bound to the surface of MR1 in a 
hapten-like manner? Was there a defined antigen-binding pocket? Were there other (unidentified) 
ligands captured by MR1 in this process that had not been detected by mass spectrometry? The 
crystal structure of the MR1-6-FP complex began to resolve some of these central questions. It 
revealed that MR1 indeed adopted an MHC-I-fold, within which 6-FP was sequestered deep within 
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the base of the MR1 Ag-binding cleft.  Here, within the A'-pocket, 6-FP was surrounded by a large 
number of aromatic residues. The structure of the MR1 Ag-binding cleft was distinct from the Ag-
binding clefts of MHC and CD1, which capture peptides and lipids respectively, and demonstrated 
the versatility of the MHC fold to capture three classes of Ags. Indeed, the binding pocket of MR1 
appeared to be ideally suited to capture small aromatic molecules. An additional surprise, revealed 
by the crystal structure, was that 6-FP was covalently bonded to MR1 through a Schiff base linkage 
(chemically known as an imine, a carbon-nitrogen double bond) formed between the formyl group of 
6-FP and the side chain e-amine of lysine 43 of MR1. Such a covalent interaction between an Ag and 
Ag-presenting molecule had not been observed previously, and has subsequently been shown to act 
as a ‘molecular switch’ that enables MR1 to egress from the endoplasmic reticulum 35.  
 
Whilst 6-FP was presented by MR1, it did not activate MAIT cells, and neither did other ligands 
from the folate pathway. This suggested that MAIT cells must be activated by a different ligand. It 
was also observed that MAIT cell activation was inhibited when both non-activating 6-FP and 
activating S. Typhimurium supernatant or synthetic ligands were added together to Jurkat.MAIT and 
C1R.MR1 cells 36, 37. The inhibitory effect was specific to 6-FP and the MAIT-MR1 interaction and not 
observed with other pteridine analogues of folate, such as 6,7-dimethylpterin, 6-
hydroxymethylpterin, or 6-hydroxymethyl-7,8-dihydropterin.  
 
In later experiments, we identified an analogue of 6-FP, N-acetyl-6-formylpterin (Ac-6-FP) (Figure 
2b), which also engendered efficient folding of MR1. Ac-6-FP was more potent than 6-FP in 
inhibiting activation of Jurkat.MAIT cells by S. Typhimurium supernatant in the presence of 
C1R.MR1 cells (unpublished). In much later experiments we showed that repeated intranasal 
delivery of Ac-6-FP to C57BL/6 mice inhibited MAIT cell activation by stimulatory Ags in the lungs 
of mice 38. Thus, we had identified 6-FP and Ac-6-FP as small molecule antagonists, capable of 
blocking activation of MAIT cells by ligands from bacteria via competitive inhibition. However, the 
activating ligand in Salmonella supernatant remained elusive. 
 
 
Discovery of MR1 bound antigens that activate MAIT cells 
 
Identification of the riboflavin biosynthesis pathway as the source of MAIT cell antigens  
The discovery that a vitamin B9 degradation product, 6-FP, was captured from RPMI and acted as a 
non-stimulatory MAIT cell Ag, led us to hypothesise that the active MR1-bound ligand may be 
competed from MR1-binding by the abundance of 6-FP in culture supernatants.  Thus, we reasoned 
that the capture and identification of activating Ag(s) by MR1 might be more efficient if culture 
conditions minimized the levels of folate in the medium. This was achieved by growing S. 
Typhimurium in a minimal medium (M9), that lacked vitamin B9. Indeed, supernatant of S. 
Typhimurium grown in M9 media, but not the control M9 media alone, activated Jurkat.MAIT cells 
in the presence of C1R.MR1 cells and engendered folding of MR1 with b2m. High resolution mass 
spectrometry of the ligand, subsequently eluted from MR1, allowed determination of the m/z 329.11 
in negative ion mode. Upon examining isotopic mass distribution in the mass spectrometry 
experiments, the ligand could be unambiguously assigned to the formula C12H18N4O7. A database 
search of compounds with this composition and m/z yielded no match, but some ribityllumazine 
compounds from the riboflavin (vitamin B2) biosynthetic pathway were close, such as 7-hydroxy-6-
methyl-8-D-ribityllumazine (RL-6-Me-7-OH, C12H16N4O7, m/z 327.0946 in negative ion mode) and 
6,7-dimethyl-8-D-ribityllumazine (RL-6,7-diMe, C13H18N4O6, m/z 325.1153 in negative ion mode) 
(Figure 3). It was noted from two key studies 2, 21 that only microbes that activated MAIT cells 
possessed a complete riboflavin biosynthetic pathway (Table 1) 30. Thus, it became apparent that a 
riboflavin metabolite may be an activating MAIT cell ligand. 
Deleted: activating 
Deleted: the dominant ligand 
2018 ICB Special Feature Review – MAIT cells 
 
The gold standard in assigning a given Ag to T cell activation is the ability to recapitulate candidate 
Ag activity with pure, structurally well-defined compounds produced by chemical synthesis. Whilst 
RL-6-Me-7-OH and RL-6,7-diMe were unstable and challenging to synthesize, they were obtained 
in sufficient quantities for functional assays. Both compounds specifically activated Jurkat.MAIT 
cells in the presence of C1R.MR1 cells in an MR1-dependent manner, although the levels of 
activation were very modest, and much lower than the activity observed for S. Typhimurium 
supernatant 30.  
 
 
Structural basis of MAIT TCR recognition of MR1-RL-6-Me-7-OH versus MR1-6-FP 
The molecular basis for the lack of activation of MAIT cells by 6-FP in the face of activation by 
riboflavin-derived ligands was resolved in crystal structures of the MAIT TCR-MR1-Ag ternary 
complexes with 6-FP and RL-6-Me-7-OH. In order to improve the inefficient folding of MR1 with 
our synthetic ligands, we had also made use of an unexpected finding, namely that the lysine to 
alanine (K43A) mutant, MR1-K43A could be folded with b2m in the absence of ligand (designated 
“empty” MR1-K43A). RL-6-Me-7-OH could thus also be loaded into “empty” MR1-K43A and its 
structure determined 5. The high resolution to which these MAIT TCR ternary complexes were 
resolved allowed for unambiguous assignment of the small molecule Ags within these complexes. 36. 
These ternary structures revealed that MR1 could capture RL-6-Me-7-OH and 6-FP within the MR1 
cleft. Although 6-FP formed a covalent Schiff base adduct with MR1, whereas RL-6-Me-7-OH 
cannot and was instead non-covalently bound, the overall docking topologies of the TCRs onto MR1 
bound to these ligands were very similar. The ribityl moiety of RL-6-Me-7-OH was directly 
contacted via a hydrogen bond with the highly conserved Tyr 95 of the MAIT TCR a-chain. In 
contrast, there were no direct TCR contacts with 6-FP, which lacks the ribityl moiety. This 
observation provided a mechanism for the activation of MAIT cells by RL-6-Me-7-OH, as compared 
to the inhibition by 6-FP. It also suggested a basis for the dominant selection of TRAJ33 by MAIT 
TCRs as this was one of only three Ja segments that contained a Tyr 95a. Together with the 
increased affinity of MAIT TCR for MR1 presenting the riboflavin metabolite over the folate ligand, 
this provided the first molecular insights into MAIT cell agonism, as well as definitive insights into 
the nature of the invariant MAIT TCR usage 36.   
 
 
rRL-6-CH2OH as a candidate MAIT cell antigen 
RL-6-Me-7-OH and RL-6,7-diMe did not match the formula C12H18N4O7, unambiguously assigned to 
the Ag derived from S. Typhimurium through isotopic mass distribution in mass spectra. Three new 
compounds could be attributed to this formula, but were not previously described in riboflavin 
biosynthesis (Figure 4). They were a dihydrogen-reduced form of the key vitamin B2 biosynthesis 
metabolite RL-6-Me-7-OH (abbreviated rRL-6-Me-7-OH); a dihydrogen-reduced form of 6-
hydroxymethyl-8-D-ribityllumazine (called rRL-6-CH2OH or rRL-6HM); or 5-(2-
oxopropylideneamino)-6-D-ribitylaminouracil (abbreviated 5-OP-RU) that was expected to be far too 
unstable to survive in water. Attempts to preserve synthetic rRL-6-Me-7-OH failed due to its 
extremely facile oxidation to RL-6-Me-7-OH, but rRL-6-CH2OH could be synthesized from the key 
intermediate 5-amino-6-D-ribitylaminouracil (5-A-RU) by condensation with 1,3-dihydroxyacetone. 
Synthetic rRL-6CH2OH, matching the m/z species of 329.11 identified from Salmonella supernatant, 
seemed to potently activate MAIT cells in an MR1-dependent manner 30. Importantly, fluorochrome-
coupled tetramers of MR1-K43A, apparently loaded with this rRL-6-CH2OH, stained human MAIT 
cells permitting their characterisation 5, and supporting the notion that we were on the right track in 
unlocking the ligand biology of MAIT cells. Later we realized that only a late eluting trace 
contaminant, identified in liquid chromatography fractions of synthetic rRL-6CH2OH, was actually 
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responsible entirely for folding MR1. We aimed to determine the crystal structure of MR1 loaded 
with synthetic rRL-6-CH2OH and complexed to a MAIT TCR. We were able to load rRL-6-CH2OH 
into “empty” MR1-K43A and determined the crystal structure in complex with a MAIT TCR 39. To 
our astonishment, instead of the expected two-ring structure of rRL-6-CH2OH, the electron density 
indicated that a one-ring structure was present. However, we remained puzzled at how this ligand 
was derived from riboflavin biosynthesis.  
 
 
A genetic approach showing that the riboflavin pathway was required for MAIT cell activation  
Given the challenges of biochemically nailing the riboflavin synthesis pathway as furnishing the 
precursor of physiological activating MAIT cell ligands, we turned to a genetic approach to 
understand the origin of MAIT cell activating ligands from microbial riboflavin synthesis (see 40 and 
Figure 3). Most of the work defining this pathway was performed using Bacillus spp.. In these, and 
other Gram-positive bacteria, including Lactococcus spp., the Rib genes are grouped into a single, 4-
gene operon (ribGBAH), which is under transcriptional regulation through a riboswitch, such that 
riboflavin or flavin mononucleotides (FMN) downregulate the further production of riboflavin 40, 41.  
 
Two recent papers demonstrate MAIT cell activation by Streptococcus pneumoniae and show that 
the riboflavin biosynthesis pathway is highly conserved amongst pneumococci and also present in 
other Streptococcus spp. 42, 43, but lacking from 2400 S. pyogenes strains 43, consistent with a previously 
reported lack of MAIT cell activation 21. In 571 pneumococci the genes (“rib DEAH”, equivalent to 
“rib GBAH”) were found clustered together in a highly conserved operon 43. 
 
Other bacteria, such as the Gram-negative E. coli and Salmonella spp., have their riboflavin 
synthesis enzyme genes dispersed throughout the genome. Production of riboflavin is also regulated 
in these species, through a number of mechanisms 41. Furthermore, although an essential pathway for 
many organisms, evolution has resulted in many gene variants (genetic solutions), including in some 
bacteria and plants where ribA and ribB are combined into a bifunctional enzyme, ribAB, and in 
yeast and plants whereby the pathway differs in this reaction step 44-46. A further complication is that 
the enzyme nomenclature also differs among bacteria. The details of riboflavin synthesis and its 
regulation are complex and still emerging, with the recent discovery of the 5-A-RU 5′-phosphate 
phosphatase in Arabidopsis thaliana 47, completing the pathway. 
 
Adding riboflavin to bacterial cultures of S. Typhimurium inhibited the activation of Jurkat.MAIT 
cells by these culture supernatants 39. Consistent with our findings, exogenous riboflavin has also 
recently been shown to decrease activation of MAIT cells by Streptococcus pneumoniae 42, 43.  In the S. 
Typhimurium genome, ribD and ribH are grouped together – thus initial experiments demonstrating 
the requirement for the riboflavin pathway in the production of MAIT cell stimulatory Ags used a 
mutant lacking both genes. S. Typhimurium SL1344 DribDH 39, and later S. Typhimurium BRD509 
DribDH 19, to demonstrate markedly decreased MAIT cell activation, and this activity could be 
reconstituted by addition to the mutants of ribDH expressed from a plasmid. 
 
To pinpoint the specific step in the pathway leading to production of MAIT cell-stimulating Ag(s), 
individual gene deficient strains were needed. Thus, the Lactococcus lactis CB013 roseoflavin 
resistant mutant 48, which constitutively expresses riboflavin and lacks the feedback mechanisms that 
complicated earlier attempts, was used to construct a set of gene deficient bacteria lacking individual 
rib genes (generated by our collaborator, Jennifer Mahoney). In these experiments 39, ribA and ribG 
mutant strains (ribD in Salmonella) clearly abrogated MAIT cell activation, whereas ribB and ribH 
did not. Additionally, alongside results from wt S. Typhimurium (+ve for 329.11 species) and 
Enterococcus faecalis (-ve), the ability of supernatant from these mutants to drive MR1 folding and 
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identification of the m/z 329.11 species by mass spectrometry correlated with activity in 
Jurkat.MAIT cell activation assays 39. Taken together, these experiments definitively pinpointed the 
key metabolite necessary to generate activating MAIT cell ligands as 5-amino-6-D-ribitylaminouracil 
(5-A-RU). These studies have now been recapitulated for E. coli and S. pneumoniae by other groups, 
and also demonstrate the requirement for ribD/G in these bacteria 43, 49. 
 
Multiple strands of evidence came together in an overlapping sequence of discoveries to identify the 
MAIT cell Ag formed from 5-A-RU. The collective evidence leveraged the contributions of all three 
laboratories collaborating on the project. These included insights from the old biochemical literature 
and associated data, X-ray crystallographic structures of MR1-Ag complexes bound to a MAIT TCR 
and fundamental chemistry considerations.  
 
Clues from the biochemical and chemical literature 
While 5-A-RU alone appeared to stimulate Jurkat.MAIT cells, its m/z in negative ion mode 
(C9H16N4O6, m/z 275.09) was about 54 units smaller than the m/z of the Ag derived from S. 
Typhimurium, 329.11. Also, we could readily fold MR1 in the presence of 5-A-RU, which was 
colourless but became intensely yellow on storage, matching the faint yellow colour occasionally 
observed when MR1 was folded in the presence of Salmonella supernatant. However, mass 
spectrometry of the resulting purified MR1-Ag, gave an m/z 315.09 (negative ion mode), or 40 units 
larger than the m/z of 5-A-RU and 14 units smaller than the m/z of the Ag derived from S. 
Typhimurium, 329.11. Thus, we were left with a biochemical puzzle. 
 
Further molecular insights came from reviewing the literature on 5-A-RU as part of the riboflavin 
synthesis. A key publication from Bacher’s team predicted that en route to producing the 
ribityllumazine RL-6,7-diMe during riboflavin synthesis, 5-A-RU forms a Schiff base with 3,4-
dihydroxy-2-butanone-4-phosphate (3,4-DH-2-B-4-P) to yield an unstable ring-opened pyrimidine 
intermediate, 5-(1-methyl-2-oxopropylideneamino)-6-D-ribitylaminouracil (5-MOP-RU, C13H20N4O7, 
m/z 343.13) 50. Bacher’s team also showed, that the reaction of the riboflavin pathway catalysed by 
the lumazine synthase (RibH) could also occur spontaneously, in the absence of any enzymatic 
catalysis. Hence, both 3,4-dihydroxy-2-butanone-4-phosphate and upon dephosphorylation, 2,3-
butanedione, could form a Schiff base with 5-A-RU 40, 51. This suggested that other small molecules 
might spontaneously undergo similar reactions during in vitro folding, one of which might generate 
the dominant m/z 329.11 product derived from S. Typhimurium culture supernatant and another the 
m/z 315.09 species observed following folding of MR1 in the presence of 5-A-RU. Indeed, 
methylglyoxal, lacking a methyl group compared to 2,3-butanedione, would be expected to form a 
Schiff base with 5-A-RU to yield 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil (5-OP-RU, 
C12H18N4O7), matching the m/z of 329.11 in negative ion mode, a compound theoretically generated en 
route to creating 7-methyl-8-D-ribityllumazine (RL-7-Me) (Figure 5). Similarly, we reasoned that it 
was glyoxal, lacking two methyl groups compared to 2,3-butanedione, that had formed a Schiff base 
with 5-A-RU to yield 5-(2-oxoethylideneamino)-6-D-ribitylaminouracil (5-OE-RU, C11H16N4O7). By 
analogy with 5-OP-RU, 5-OE-RU was theoretically generated en route to creating 8-D-
ribityllumazine (RL) (Figure 5). 
 
Aiming to generate MR1 loaded with 5-OP-RU, we initially folded MR1 in the presence of 
equimolar amounts of 5-A-RU and methylglyoxal. Whilst the dominant species remained m/z 315.09 
we now observed a minor m/z 329.11 species. Using a molar excess of methylglyoxal (an arbitrary 
molar excess of over 300-fold was chosen), we did however solely identify m/z 329.11. MR1 
tetramers with both species effectively stained MAIT cells 39, and unpublished. Moreover, when re-
examining mass spectrometry of MR1 folded in the presence of Salmonella supernatant we observed 
a minor m/z 315.09 next to the dominant m/z of 329.11. Also folding of MR1 in the presence of E. 
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coli (DH5a) supernatant gave a distinct, more abundant, m/z 315.09 in comparison to a m/z 329.11 
species 39, consistent with the findings of others 49. Thus, we reasoned that both the m/z 315.09 and 
329.11 species were likely acting as potent, natural MAIT cell Ags. Notably, both glyoxal and 
methylglyoxal are formed from a number of metabolic pathways, including mammalian and bacterial 
glycolysis (Wang and Ho, 2012) and glyoxal is widely abundant as it is produced industrially as a 
precursor to many products (Mattioda and Blanc, 2000). The almost ubiquitous presence of glyoxal 
explained the presence of the m/z 315.09 species in refolds of MR1 with pure 5-A-RU alone, 
whereby folding yields could be increased by adding additional glyoxal. 
 
 
The structural basis for ligand selectivity by MR1  
To understand the basis for ligand selectivity by MR1, we determined high resolution crystal 
structures of the MAIT TCR in complex with MR1 folded in the presence of 5-A-RU and 
methylglyoxal or glyoxal 39. In both structures the electron density at the site of the Ag binding 
pocket was unambiguously matching 5-OP-RU and 5-OE-RU, respectively. Analogous to 6-FP, the 
carbonyl groups derived from methylglyoxal and glyoxal when forming 5-OP-RU and 5-OE-RU, 
respectively, extended to Lysine 43 of MR1 to form a Schiff base. The Ags were further stabilized in 
MR1 through an extensive hydrogen-bonding network. As with RL-6-Me-7-OH, the ribityl chain of 
5-OP-RU and 5-OE-RU were also directly contacted by the Tyr 95 of the MAIT TCR a-chain and 
an additional water-mediated hydrogen bond was mediated by the CDR3β loop of the TCR. The 
affinities of MR1-5-OP-RU or MR1-5-OE-RU complexes with MAIT TCRs, measured by surface 
plasmon resonance, were comparable to those with conventional TCRs recognizing MHC-peptide 
complexes (Kdeq ∼ 0.5–10 μM) 39, 52. 
 
When we determined the crystal structure of MAIT TCR complexed with the mutant MR1-K43A 
loaded apparently with synthetic rRL-6-CH2OH, we found that the Ag bound to MR1 was instead 5-
OP-RU 39. This was consistent with HPLC chromatograms of synthetic rRL-6-CH2OH, which showed 
a late eluting trace contaminant that proved to be entirely responsible for folding MR1. The retention 
time matched that of the Ag derived from S. Typhimurium, under the same chromatographic 
conditions. Given that Schiff base formation was not possible with MR1-K43A, it became clear that 
a Schiff base was not obligatory for ligation of 5-OP-RU. Other interactions with MR1 were 
evidently sufficient for MR1 to ligate the Ag and prevent its cyclisation to a ribityllumazine. 
However, the lack of a covalent Schiff base bond to MR1 impacted profoundly on the stability of the 
Ag-MR1 complex, which was markedly reduced (17°C lower half-maximum melting temperature by 
thermostability) 37. Unlike 5-OP-RU, 5-A-RU alone, however, could not be loaded into MR1-K43A 
(unpublished).   
 
Neither 5-OP-RU nor 5-OE-RU were previously known to exist naturally, and they are the first 
examples of organic heterocycles as T cell Ags. However, they are also chemically very unstable in 
water where they cyclise to ribityllumazines in minutes at 37°C. A synthesis was therefore devised to 
produce 5-OP-RU and 5-OE-RU in dimethylsulfoxide, where they were indefinitely stable and could 
be extensively characterized in solution by NMR spectroscopy 39. Later this method was further 
optimised to provide a reliable source of pure MAIT cell Ags for studying their chemical reactivity 53 
and MAIT cell activation in vitro and in vivo 19. 
 
In summary, instead of capturing the thermodynamically more stable ribityllumazines, MR1 prefers 
to sequester a thermodynamically unstable pyrimidine intermediate formed transiently through 
condensation of compounds arising from two distinct metabolic pathways, 5-A-RU from the 
bacterial biosynthesis of riboflavin and methylglyoxal/glyoxal from bacterial or mammalian 
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glycolysis. This confirmed our hypothesis that the way MR1 Ags are created and captured is unique 
amongst T cell Ags 39. 
 
Reflections on MR1 antigen diversity  
 
Classical MHC-I molecules have evolved under strong positive, diversifying, selection 54 causing 
them to be highly polymorphic. Whilst not formally investigated, MR1 appears monomorphic 9, 11 and 
the high conservation of the MR1 Ag binding site across species indicates that it has evolved under 
strong negative, purifying, selection 22. Early on, this, together with the semi-invariant MAIT TCR 
usage composed of a nearly invariant TCR a-chain and a limited array of TCR b-chains, led to the 
hypothesis that MAIT cells might recognise a single Ag or a limited number of Ags 1, 6, 10. Following 
the finding that MAIT cells recognise a broad array of both bacteria and yeast species, the hypothesis 
was further refined: ‘MAIT cell Ags were either extremely conserved between microbial species or 
TCRs would be non-discriminative’ 21, contrasting with the exquisite fine-specificity of conventional 
TCRs recognising structurally related peptide Ags 55.  
 
Indeed, we discovered several activating MAIT cell Ags and they fit both hypotheses: There is 
substantial evidence that MR1 focuses on a metabolic pathway that is conserved between many 
microbial species, namely the riboflavin pathway derived pyrimidine 39 and ribityllumazine 30, 36 Ags. 
Given the various versions of the riboflavin pathway, and their modifications, variants of 5-A-RU 
and ribityllumazines might exist. Also, physiological by-products other than methylglyoxal and 
glyoxal might be capable of forming a Schiff base with both MR1 and 5-A-RU, thus forming Ags 
around a generic scaffold that could differ based on the microbe as previously described for 5-OP-
RU versus 5-OE-RU 39, or metabolic stage of the microbe or host that might also differ in different 
tissues. At the same time, whilst related, pyrimidines and ribityllumazines are structurally different 
yet both recognised by the same MAIT TCRs in a pattern-recognition like manner 37. 
 
Whilst MR1 likely presents a limited number of Ags, this is matched with a large precursor 
frequency of responding MAIT cells, that exceeds the number of T cells available to recognise any 
peptide-MHC Ag 56, allowing for a rapid powerful response. Notably, there is appreciable variation in 
the MAIT TCR b-chain repertoire, especially in the CDR3b loop, which also displays remarkable 
structural plasticity when fine-tuning MR1 recognition in an Ag-dependent manner 37. Furthermore, 
the TCR a-chain can feature diversity beyond the canonical TRAV1-2-TRAJ33 rearrangement, 
where frequently also TRAJ12 and 20 are used 4, 5, 57 but also other TRAJ segments including some that 
lack the Tyr 95 residue 58, that was shown to be pivotal in MAIT cell activation, hydrogen bonding 
with the ribityl moiety of activating Ags 4, 5, 27, 36, 37, 39, 57, 59. Furthermore diverse TRAV1-2- TCRs with 
various reactivity patterns have been described: (i) some reacted like classical MAIT TCRs with 
MR1-5-OP-RU tetramers only 57; (ii) others reacted with both tetramers with folic acid derived 
ligands and 5-OP-RU 57, or in one case responded to both riboflavin pathway derived Ags and a 
riboflavin deficient microbe (S. pyogenes) 60 and as such overlapped with the classical MAIT cell 
reactivity; (iii) a third type reacted with tetramers with folic acid derived ligands only 57 or responded 
to self-Ags only 61 and as such was not overlapping with the classical MR1-5-OP-RU reactive T cell 
subset. Gold et al. 58 also observed distinct MAIT TCR repertoire mobilization in response to diverse 
pathogens that could reflect the existence of discrete pathogen-associated Ags presented by MR1. 
TRAV1-2- MR1 restricted T cells, as investigated by Gherardin et al., also lacked the MAIT cell 
lineage-specific transcription factors PLZF and RORγt and were heterogeneous for T-bet, suggesting 
developmental and functional differences compared to the TRAV1-2+ MAIT cells 57.  
 
Thus, additional natural Ags presented by MR1 might exist and be recognised by TCRs in a subset 
specific manner. This is also further supported by our observation that MR1 has the versatility and 
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plasticity to accommodate structurally diverse drugs, drug metabolites and drug analogues in the A’-
pocket 38. In addition, Ags might bind in the F’-pocket of MR1, mirroring our observation of 
crystallisation buffer molecules in the F’-pocket of TCR-MR1-Ag crystal structures 52. It will be 
important to identify the chemical structures, metabolic origin and physiological relevance of any 
newly identified natural Ags, requiring careful functional, biochemical and structural 
characterisation. 
 
 
Where to next 
 
The discovery of the 5-OP-RU and 5-OE-RU as very potent Ags and development of MR1-tetramers 
5, 39, now available from the National Institutes of Health, U. S. A., have opened up the field to start 
elucidating the roles of MAIT cells in anti-microbial immunity 19, 62-64, in sensing of metabolic changes 
such as in cancer stress and cell damage 61, 65, as well as in immunopathology 66-68. The tetramers have 
also allowed further characterisation of the phenotypic identity of MAIT cells, with various subsets. 
Furthermore, their development and individual and age specific differences are being investigated 69-71. 
There is still much to be understood about the identity and functions of MAIT cells, including their 
roles in immunity and disease, which in our experience seem much harder to nail. 
 
 
 
 
Figure legends  
 
Figure 1 
Schematic of ‘Ag-fishing’ or bioprospecting, whereby denatured MR1 and b2m serve as ‘bait’ to 
‘fish’ potential Ags, such as 5-OP-RU and 6-FP, from complex metabolic mixtures in bacterial 
supernatants. 
 
Figure 2 
MR1 ligands that act as competitive inhibitors of MAIT cell activation. a) Photodegradation of folic 
acid in ultraviolet light to 6-formylpterin and p-aminobenzoyl-L-glutamic acid.  b) Acetyl-6-
formylpterin, a synthetic analogue of 6-formylpterin. Chemical structures, formulas and m/z in 
negative ion mode are indicated. 
 
Figure 3 
Riboflavin biosynthesis pathway. ribH, lumazine synthase; X, hypothetical phosphatase. Chemical 
structures are indicated. 
 
Figure 4 
Structures of three regioisomers (m/z 329.11, negative ion mode) that have the same molecular 
formula C12H18N4O7: rRL-6-Me-7-OH and rRL-6-CH2OH and that can be derived non-enzymatically 
from the key vitamin B2 biosynthesis intermediate 5-A-RU. 
 
Figure 5 
Formation of pyrimidines and ribityllumazines from condensation of small metabolites with 5-A-
RU. Chemical structures are indicated. 
 
 
 
2018 ICB Special Feature Review – MAIT cells 
 
 
Acknowledgements 
 
This work was supported by Program Grants 1016629 and 1113293 and Project Grants 1062889, 
1125493, and 1120467 from the National Health and Medical Research Council of Australia and by 
a Merieux Research Grant. A.J.C. is supported by an Australian Research Council Future 
Fellowship. D.I.G. and D.P.F. are supported by National Health and Medical Research Council 
Senior Principal Research Fellowships. J.R. is supported by an Australian Research Council Laureate 
Fellowship. S.B.G.E. is supported by an Australian Research Council Discovery Early Career 
Researcher Award Fellowship.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2018 ICB Special Feature Review – MAIT cells 
 
 
References 
 
1. Porcelli S, Yockey CE, Brenner MB, Balk SP. Analysis of T cell antigen receptor (TCR) 
expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential 
use of several V beta genes and an invariant TCR alpha chain. The Journal of experimental 
medicine 1993; 178(1): 1-16. 
 
2. Gold MC, Cerri S, Smyk-Pearson S, Cansler ME, Vogt TM, Delepine J et al. Human 
mucosal associated invariant T cells detect bacterially infected cells. PLoS biology 2010; 
8(6): e1000407. 
 
3. Gold MC, Lewinsohn DM. Co-dependents: MR1-restricted MAIT cells and their 
antimicrobial function. Nature reviews. Microbiology 2013; 11(1): 14-9. 
 
4. Lepore M, Kalinichenko A, Colone A, Paleja B, Singhal A, Tschumi A et al. Parallel T-cell 
cloning and deep sequencing of human MAIT cells reveal stable oligoclonal TCRbeta 
repertoire. Nature communications 2014; 5: 3866. 
 
5. Reantragoon R, Corbett AJ, Sakala IG, Gherardin NA, Furness JB, Chen Z et al. Antigen-
loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T 
cells. The Journal of experimental medicine 2013; 210(11): 2305-20. 
 
6. Tilloy F, Treiner E, Park SH, Garcia C, Lemonnier F, de la Salle H et al. An invariant T cell 
receptor alpha chain defines a novel TAP-independent major histocompatibility complex 
class Ib-restricted alpha/beta T cell subpopulation in mammals. The Journal of experimental 
medicine 1999; 189(12): 1907-21. 
 
7. Goldfinch N, Reinink P, Connelley T, Koets A, Morrison I, Van Rhijn I. Conservation of 
mucosal associated invariant T (MAIT) cells and the MR1 restriction element in ruminants, 
and abundance of MAIT cells in spleen. Veterinary research 2010; 41(5): 62. 
 
8. Hashimoto K, Hirai M, Kurosawa Y. A gene outside the human MHC related to classical 
HLA class I genes. Science (New York, N.Y.) 1995; 269(5224): 693-5. 
 
9. Riegert P, Wanner V, Bahram S. Genomics, isoforms, expression, and phylogeny of the 
MHC class I-related MR1 gene. Journal of immunology (Baltimore, Md. : 1950) 1998; 
161(8): 4066-77. 
 
10. Treiner E, Duban L, Bahram S, Radosavljevic M, Wanner V, Tilloy F et al. Selection of 
evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 2003; 
422(6928): 164-9. 
 
11. Parra-Cuadrado JF, Navarro P, Mirones I, Setien F, Oteo M, Martinez-Naves E. A study on 
the polymorphism of human MHC class I-related MR1 gene and identification of an MR1-
like pseudogene. Tissue antigens 2000; 56(2): 170-2. 
 
12. Boudinot P, Mondot S, Jouneau L, Teyton L, Lefranc MP, Lantz O. Restricting nonclassical 
MHC genes coevolve with TRAV genes used by innate-like T cells in mammals. 
2018 ICB Special Feature Review – MAIT cells 
Proceedings of the National Academy of Sciences of the United States of America 2016; 
113(21): E2983-92. 
 
13. Greene JM, Dash P, Roy S, McMurtrey C, Awad W, Reed JS et al. MR1-restricted mucosal-
associated invariant T (MAIT) cells respond to mycobacterial vaccination and infection in 
nonhuman primates. Mucosal immunology 2017; 10(3): 802-813. 
 
14. Huang S, Martin E, Kim S, Yu L, Soudais C, Fremont DH et al. MR1 antigen presentation to 
mucosal-associated invariant T cells was highly conserved in evolution. Proceedings of the 
National Academy of Sciences of the United States of America 2009; 106(20): 8290-5. 
 
15. Lopez-Sagaseta J, Dulberger CL, Crooks JE, Parks CD, Luoma AM, McFedries A et al. The 
molecular basis for Mucosal-Associated Invariant T cell recognition of MR1 proteins. 
Proceedings of the National Academy of Sciences of the United States of America 2013; 
110(19): E1771-8. 
 
16. Lopez-Sagaseta J, Dulberger CL, McFedries A, Cushman M, Saghatelian A, Adams EJ. 
MAIT recognition of a stimulatory bacterial antigen bound to MR1. Journal of immunology 
(Baltimore, Md. : 1950) 2013; 191(10): 5268-77. 
 
17. Dusseaux M, Martin E, Serriari N, Peguillet I, Premel V, Louis D et al. Human MAIT cells 
are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood 2011; 
117(4): 1250-9. 
 
18. Tang XZ, Jo J, Tan AT, Sandalova E, Chia A, Tan KC et al. IL-7 licenses activation of 
human liver intrasinusoidal mucosal-associated invariant T cells. Journal of immunology 
(Baltimore, Md. : 1950) 2013; 190(7): 3142-52. 
 
19. Chen Z, Wang H, D'Souza C, Sun S, Kostenko L, Eckle SB et al. Mucosal-associated 
invariant T-cell activation and accumulation after in vivo infection depends on microbial 
riboflavin synthesis and co-stimulatory signals. Mucosal immunology 2016. 
 
20. Rahimpour A, Koay HF, Enders A, Clanchy R, Eckle SBG, Meehan B et al. Identification of 
phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells 
using MR1 tetramers. Journal of Experimental Medicine 2015; 212(7): 1095-1108. 
 
21. Le Bourhis L, Martin E, Peguillet I, Guihot A, Froux N, Core M et al. Antimicrobial activity 
of mucosal-associated invariant T cells. Nature immunology 2010; 11(8): 701-8. 
 
22. Hansen TH, Huang S, Arnold PL, Fremont DH. Patterns of nonclassical MHC antigen 
presentation. Nature immunology 2007; 8(6): 563-8. 
 
23. Miley MJ, Truscott SM, Yu YY, Gilfillan S, Fremont DH, Hansen TH et al. Biochemical 
features of the MHC-related protein 1 consistent with an immunological function. Journal of 
immunology (Baltimore, Md. : 1950) 2003; 170(12): 6090-8. 
 
24. Yamaguchi H, Hashimoto K. Association of MR1 protein, an MHC class I-related molecule, 
with beta(2)-microglobulin. Biochemical and biophysical research communications 2002; 
290(2): 722-9. 
 
2018 ICB Special Feature Review – MAIT cells 
25. Okamoto N, Kanie O, Huang YY, Fujii R, Watanabe H, Shimamura M. Synthetic alpha-
mannosyl ceramide as a potent stimulant for an NKT cell repertoire bearing the invariant 
Valpha19-Jalpha26 TCR alpha chain. Chemistry & biology 2005; 12(6): 677-83. 
 
26. Shimamura M, Huang YY, Okamoto N, Suzuki N, Yasuoka J, Morita K et al. Modulation of 
Valpha19 NKT cell immune responses by alpha-mannosyl ceramide derivatives consisting of 
a series of modified sphingosines. European journal of immunology 2007; 37(7): 1836-44. 
 
27. Reantragoon R, Kjer-Nielsen L, Patel O, Chen Z, Illing PT, Bhati M et al. Structural insight 
into MR1-mediated recognition of the mucosal associated invariant T cell receptor. The 
Journal of experimental medicine 2012; 209(4): 761-74. 
 
28. Huang S, Gilfillan S, Cella M, Miley MJ, Lantz O, Lybarger L et al. Evidence for MR1 
antigen presentation to mucosal-associated invariant T cells. The Journal of biological 
chemistry 2005; 280(22): 21183-93. 
 
29. Garboczi DN, Hung DT, Wiley DC. HLA-A2-peptide complexes: refolding and 
crystallization of molecules expressed in Escherichia coli and complexed with single 
antigenic peptides. Proceedings of the National Academy of Sciences of the United States of 
America 1992; 89(8): 3429-33. 
 
30. Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J, Meehan B, Liu L et al. MR1 presents 
microbial vitamin B metabolites to MAIT cells. Nature 2012; 491(7426): 717-23. 
 
31. Off MK, Steindal AE, Porojnicu AC, Juzeniene A, Vorobey A, Johnsson A et al. Ultraviolet 
photodegradation of folic acid. Journal of photochemistry and photobiology. B, Biology 
2005; 80(1): 47-55. 
 
32. Chua WJ, Kim S, Myers N, Huang S, Yu L, Fremont DH et al. Endogenous MHC-related 
protein 1 is transiently expressed on the plasma membrane in a conformation that activates 
mucosal-associated invariant T cells. Journal of immunology (Baltimore, Md. : 1950) 2011; 
186(8): 4744-50. 
 
33. Ljunggren HG, Stam NJ, Ohlen C, Neefjes JJ, Hoglund P, Heemels MT et al. Empty MHC 
class I molecules come out in the cold. Nature 1990; 346(6283): 476-80. 
 
34. Juzeniene A, Grigalavicius M, Ma LW, Juraleviciute M. Folic acid and its photoproducts, 6-
formylpterin and pterin-6-carboxylic acid, as generators of reactive oxygen species in skin 
cells during UVA exposure. Journal of photochemistry and photobiology. B, Biology 2016; 
155: 116-21. 
 
35. McWilliam HE, Eckle SB, Theodossis A, Liu L, Chen Z, Wubben JM et al. The intracellular 
pathway for the presentation of vitamin B-related antigens by the antigen-presenting 
molecule MR1. Nature immunology 2016; 17(5): 531-7. 
 
36. Patel O, Kjer-Nielsen L, Le Nours J, Eckle SB, Birkinshaw R, Beddoe T et al. Recognition of 
vitamin B metabolites by mucosal-associated invariant T cells. Nature communications 2013; 
4: 2142. 
 
2018 ICB Special Feature Review – MAIT cells 
37. Eckle SB, Birkinshaw RW, Kostenko L, Corbett AJ, McWilliam HE, Reantragoon R et al. A 
molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated 
invariant T cells. The Journal of experimental medicine 2014; 211(8): 1585-600. 
 
38. Keller AN, Eckle SB, Xu W, Liu L, Hughes VA, Mak JY et al. Drugs and drug-like 
molecules can modulate the function of mucosal-associated invariant T cells. Nature 
immunology 2017; 18(4): 402-411. 
 
39. Corbett AJ, Eckle SB, Birkinshaw RW, Liu L, Patel O, Mahony J et al. T-cell activation by 
transitory neo-antigens derived from distinct microbial pathways. Nature 2014; 509(7500): 
361-5. 
 
40. Bacher A, Eberhardt S, Fischer M, Kis K, Richter G. Biosynthesis of vitamin b2 (riboflavin). 
Annual review of nutrition 2000; 20: 153-67. 
 
41. Vitreschak AG, Rodionov DA, Mironov AA, Gelfand MS. Regulation of riboflavin 
biosynthesis and transport genes in bacteria by transcriptional and translational attenuation. 
Nucleic acids research 2002; 30(14): 3141-51. 
 
42. Hartmann N, McMurtrey C, Sorensen ML, Huber ME, Kurapova R, Coleman FT et al. 
Riboflavin Metabolism Variation Among Clinical Isolates of Streptococcus pneumoniae 
Results in Differential Activation of MAIT Cells. American journal of respiratory cell and 
molecular biology 2018. 
 
43. Kurioka A, van Wilgenburg B, Javan RR, Hoyle R, van Tonder AJ, Harrold CL et al. Diverse 
Streptococcus pneumoniae strains drive a MAIT cell response through MR1-dependent and 
cytokine-driven pathways. The Journal of infectious diseases 2017. 
 
44. Brutinel ED, Dean AM, Gralnick JA. Description of a riboflavin biosynthetic gene variant 
prevalent in the phylum Proteobacteria. Journal of bacteriology 2013; 195(24): 5479-86. 
 
45. Fischer M, Bacher A. Biosynthesis of vitamin B2 in plants. Physiologia Plantarum 2006; 
126(3): 304-318. 
 
46. Herz S, Eberhardt S, Bacher A. Biosynthesis of riboflavin in plants. The ribA gene of 
Arabidopsis thaliana specifies a bifunctional GTP cyclohydrolase II/3,4-dihydroxy-2-
butanone 4-phosphate synthase. Phytochemistry 2000; 53(7): 723-31. 
 
47. Sa N, Rawat R, Thornburg C, Walker KD, Roje S. Identification and characterization of the 
missing phosphatase on the riboflavin biosynthesis pathway in Arabidopsis thaliana. The 
Plant journal : for cell and molecular biology 2016; 88(5): 705-716. 
 
48. Burgess C, O'Connell-Motherway M, Sybesma W, Hugenholtz J, van Sinderen D. Riboflavin 
production in Lactococcus lactis: potential for in situ production of vitamin-enriched foods. 
Appl Environ Microbiol 2004; 70(10): 5769-77. 
 
49. Soudais C, Samassa F, Sarkis M, Le Bourhis L, Bessoles S, Blanot D et al. In Vitro and In 
Vivo Analysis of the Gram-Negative Bacteria-Derived Riboflavin Precursor Derivatives 
Activating Mouse MAIT Cells. Journal of immunology (Baltimore, Md. : 1950) 2015. 
 
2018 ICB Special Feature Review – MAIT cells 
50. Cushman M, Yang D, Gerhardt S, Huber R, Fischer M, Kis K et al. Design, synthesis, and 
evaluation of 6-carboxyalkyl and 6-phosphonoxyalkyl derivatives of 7-oxo-8-
ribitylaminolumazines as inhibitors of riboflavin synthase and lumazine synthase. The 
Journal of organic chemistry 2002; 67(16): 5807-16. 
 
51. Kis K, Kugelbrey K, Bacher A. Biosynthesis of riboflavin. The reaction catalyzed by 6,7-
dimethyl-8-ribityllumazine synthase can proceed without enzymatic catalysis under 
physiological conditions. The Journal of organic chemistry 2001; 66(8): 2555-9. 
 
52. Eckle SB, Corbett AJ, Keller AN, Chen Z, Godfrey DI, Liu L et al. Recognition of Vitamin B 
Precursors and Byproducts by Mucosal Associated Invariant T Cells. The Journal of 
biological chemistry 2015; 290(51): 30204-11. 
 
53. Mak JY, Xu W, Reid RC, Corbett AJ, Meehan BS, Wang H et al. Stabilizing short-lived 
Schiff base derivatives of 5-aminouracils that activate mucosal-associated invariant T cells. 
Nature communications 2017; 8: 14599. 
 
54. Hughes AL, Nei M. Pattern of nucleotide substitution at major histocompatibility complex 
class I loci reveals overdominant selection. Nature 1988; 335(6186): 167-70. 
 
55. Wucherpfennig KW, Allen PM, Celada F, Cohen IR, De Boer R, Garcia KC et al. 
Polyspecificity of T cell and B cell receptor recognition. Seminars in immunology 2007; 
19(4): 216-24. 
 
56. Godfrey DI, Uldrich AP, McCluskey J, Rossjohn J, Moody DB. The burgeoning family of 
unconventional T cells. Nature immunology 2015; 16(11): 1114-23. 
 
57. Gherardin NA, Keller AN, Woolley RE, Le Nours J, Ritchie DS, Neeson PJ et al. Diversity 
of T Cells Restricted by the MHC Class I-Related Molecule MR1 Facilitates Differential 
Antigen Recognition. Immunity 2016; 44(1): 32-45. 
 
58. Gold MC, McLaren JE, Reistetter JA, Smyk-Pearson S, Ladell K, Swarbrick GM et al. MR1-
restricted MAIT cells display ligand discrimination and pathogen selectivity through distinct 
T cell receptor usage. The Journal of experimental medicine 2014; 211(8): 1601-10. 
 
59. Young MH, U'Ren L, Huang S, Mallevaey T, Scott-Browne J, Crawford F et al. MAIT cell 
recognition of MR1 on bacterially infected and uninfected cells. PloS one 2013; 8(1): 
e53789. 
 
60. Meermeier EW, Laugel BF, Sewell AK, Corbett AJ, Rossjohn J, McCluskey J et al. Human 
TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT 
riboflavin-based antigens. Nature communications 2016; 7: 12506. 
 
61. Lepore M, Kalinichenko A, Calogero S, Kumar P, Paleja B, Schmaler M et al. Functionally 
diverse human T cells recognize non-microbial antigens presented by MR1. eLife 2017; 6. 
 
62. Georgel P, Radosavljevic M, Macquin C, Bahram S. The non-conventional MHC class I 
MR1 molecule controls infection by Klebsiella pneumoniae in mice. Molecular immunology 
2011; 48(5): 769-75. 
 
2018 ICB Special Feature Review – MAIT cells 
63. Meierovics A, Yankelevich WJ, Cowley SC. MAIT cells are critical for optimal mucosal 
immune responses during in vivo pulmonary bacterial infection. Proceedings of the National 
Academy of Sciences of the United States of America 2013; 110(33): E3119-28. 
 
64. Chua WJ, Truscott SM, Eickhoff CS, Blazevic A, Hoft DF, Hansen TH. Polyclonal mucosa-
associated invariant T cells have unique innate functions in bacterial infection. Infection and 
immunity 2012; 80(9): 3256-67. 
 
65. Gherardin NA, Loh L, Admojo L, Davenport AJ, Richardson K, Rogers A et al. 
Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed 
and relapsed multiple myeloma. Scientific reports 2018; 8(1): 4159. 
 
66. D'Souza C, Pediongco T, Wang H, Scheerlinck JY, Kostenko L, Esterbauer R et al. Mucosal-
Associated Invariant T Cells Augment Immunopathology and Gastritis in Chronic 
Helicobacter pylori Infection. Journal of immunology (Baltimore, Md. : 1950) 2018. 
 
67. Magalhaes I, Pingris K, Poitou C, Bessoles S, Venteclef N, Kiaf B et al. Mucosal-associated 
invariant T cell alterations in obese and type 2 diabetic patients. The Journal of clinical 
investigation 2015; 125(4): 1752-62. 
 
68. Rouxel O, Da Silva J, Beaudoin L, Nel I, Tard C, Cagninacci L et al. Cytotoxic and 
regulatory roles of mucosal-associated invariant T cells in type 1 diabetes. Nature 
immunology 2017; 18(12): 1321-1331. 
 
69. Koay HF, Gherardin NA, Enders A, Loh L, Mackay LK, Almeida CF et al. A three-stage 
intrathymic development pathway for the mucosal-associated invariant T cell lineage. Nature 
immunology 2016; 17(11): 1300-1311. 
 
70. Gherardin NA, Souter MNT, Koay HF, Mangas KM, Seemann T, Stinear TP et al. Human 
blood MAIT cell subsets defined using MR1 tetramers. Immunology and cell biology 2018. 
 
71. Ben Youssef G, Tourret M, Salou M, Ghazarian L, Houdouin V, Mondot S et al. Ontogeny 
of human mucosal-associated invariant T cells and related T cell subsets. The Journal of 
experimental medicine 2018; 215(2): 459-479. 
 
72. Dias J, Leeansyah E, Sandberg JK. Multiple layers of heterogeneity and subset diversity in 
human MAIT cell responses to distinct microorganisms and to innate cytokines. Proceedings 
of the National Academy of Sciences of the United States of America 2017; 114(27): E5434-
e5443. 
 
73. Liuzzi AR, Kift-Morgan A, Lopez-Anton M, Friberg IM, Zhang J, Brook AC et al. 
Unconventional Human T Cells Accumulate at the Site of Infection in Response to Microbial 
Ligands and Induce Local Tissue Remodeling. Journal of immunology (Baltimore, Md. : 
1950) 2016; 197(6): 2195-207. 
 
74. Cosgrove C, Ussher JE, Rauch A, Gartner K, Kurioka A, Huhn MH et al. Early and 
nonreversible decrease of CD161++ /MAIT cells in HIV infection. Blood 2013; 121(6): 951-
61. 
 
2018 ICB Special Feature Review – MAIT cells 
75. D'Souza C, Pediongco T, Wang H, Scheerlinck JY, Kostenko L, Esterbauer R et al. Mucosal-
Associated Invariant T Cells Augment Immunopathology and Gastritis in Chronic 
Helicobacter pylori Infection. Journal of immunology (Baltimore, Md. : 1950) 2018; 200(5): 
1901-1916. 
 
76. Dias J, Sandberg JK, Leeansyah E. Extensive Phenotypic Analysis, Transcription Factor 
Profiling, and Effector Cytokine Production of Human MAIT Cells by Flow Cytometry. 
Methods in molecular biology (Clifton, N.J.) 2017; 1514: 241-256. 
 
77. Dias J, Sobkowiak MJ, Sandberg JK, Leeansyah E. Human MAIT-cell responses to 
Escherichia coli: activation, cytokine production, proliferation, and cytotoxicity. Journal of 
leukocyte biology 2016; 100(1): 233-40. 
 
78. Gibbs A, Leeansyah E, Introini A, Paquin-Proulx D, Hasselrot K, Andersson E et al. MAIT 
cells reside in the female genital mucosa and are biased towards IL-17 and IL-22 production 
in response to bacterial stimulation. Mucosal immunology 2017; 10(1): 35-45. 
 
79. Jeffery HC, van Wilgenburg B, Kurioka A, Parekh K, Stirling K, Roberts S et al. Biliary 
epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through 
MR1. Journal of hepatology 2016; 64(5): 1118-1127. 
 
80. Jiang J, Wang X, An H, Yang B, Cao Z, Liu Y et al. Mucosal-associated invariant T-cell 
function is modulated by programmed death-1 signaling in patients with active tuberculosis. 
American journal of respiratory and critical care medicine 2014; 190(3): 329-39. 
 
81. Jo J, Tan AT, Ussher JE, Sandalova E, Tang XZ, Tan-Garcia A et al. Toll-like receptor 8 
agonist and bacteria trigger potent activation of innate immune cells in human liver. PLoS 
pathogens 2014; 10(6): e1004210. 
 
82. Kim JS, Kang MJ, Kim WS, Han SJ, Kim HM, Kim HW et al. Essential engagement of Toll-
like receptor 2 in initiation of early protective Th1 response against rough variants of 
Mycobacterium abscessus. Infection and immunity 2015; 83(4): 1556-67. 
 
83. Kurioka A, Jahun AS, Hannaway RF, Walker LJ, Fergusson JR, Sverremark-Ekstrom E et al. 
Shared and Distinct Phenotypes and Functions of Human CD161++ Valpha7.2+ T Cell 
Subsets. Frontiers in immunology 2017; 8: 1031. 
 
84. Kurioka A, Ussher JE, Cosgrove C, Clough C, Fergusson JR, Smith K et al. MAIT cells are 
licensed through granzyme exchange to kill bacterially sensitized targets. Mucosal 
immunology 2015; 8(2): 429-40. 
 
85. Kwon YS, Cho YN, Kim MJ, Jin HM, Jung HJ, Kang JH et al. Mucosal-associated invariant 
T cells are numerically and functionally deficient in patients with mycobacterial infection and 
reflect disease activity. Tuberculosis (Edinburgh, Scotland) 2015; 95(3): 267-74. 
 
86. Le Bourhis L, Dusseaux M, Bohineust A, Bessoles S, Martin E, Premel V et al. MAIT cells 
detect and efficiently lyse bacterially-infected epithelial cells. PLoS pathogens 2013; 9(10): 
e1003681. 
 
2018 ICB Special Feature Review – MAIT cells 
87. Leeansyah E, Ganesh A, Quigley MF, Sonnerborg A, Andersson J, Hunt PW et al. 
Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell 
population in chronic HIV-1 infection. Blood 2013; 121(7): 1124-35. 
 
88. Leeansyah E, Loh L, Nixon DF, Sandberg JK. Acquisition of innate-like microbial reactivity 
in mucosal tissues during human fetal MAIT-cell development. Nature communications 
2014; 5: 3143. 
 
89. Leeansyah E, Svard J, Dias J, Buggert M, Nystrom J, Quigley MF et al. Arming of MAIT 
Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. 
PLoS pathogens 2015; 11(8): e1005072. 
 
90. Loh L, Wang Z, Sant S, Koutsakos M, Jegaskanda S, Corbett AJ et al. Human mucosal-
associated invariant T cells contribute to antiviral influenza immunity via IL-18-dependent 
activation. Proceedings of the National Academy of Sciences of the United States of America 
2016; 113(36): 10133-8. 
 
91. Salerno-Goncalves R, Rezwan T, Sztein MB. B cells modulate mucosal associated invariant 
T cell immune responses. Frontiers in immunology 2014; 4: 511. 
 
92. Salio M, Gasser O, Gonzalez-Lopez C, Martens A, Veerapen N, Gileadi U et al. Activation 
of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of 
Monocyte-Derived and Primary Dendritic Cells. Journal of immunology (Baltimore, Md. : 
1950) 2017; 199(8): 2631-2638. 
 
93. Shaler CR, Choi J, Rudak PT, Memarnejadian A, Szabo PA, Tun-Abraham ME et al. MAIT 
cells launch a rapid, robust and distinct hyperinflammatory response to bacterial 
superantigens and quickly acquire an anergic phenotype that impedes their cognate 
antimicrobial function: Defining a novel mechanism of superantigen-induced 
immunopathology and immunosuppression. PLoS biology 2017; 15(6): e2001930. 
 
94. Solders M, Gorchs L, Erkers T, Lundell AC, Nava S, Gidlof S et al. MAIT cells accumulate 
in placental intervillous space and display a highly cytotoxic phenotype upon bacterial 
stimulation. Scientific reports 2017; 7(1): 6123. 
 
95. Ussher JE, Bilton M, Attwod E, Shadwell J, Richardson R, de Lara C et al. CD161++ CD8+ 
T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-
independent manner. European journal of immunology 2014; 44(1): 195-203. 
 
96. Ussher JE, van Wilgenburg B, Hannaway RF, Ruustal K, Phalora P, Kurioka A et al. TLR 
signalling in human antigen-presenting cells regulates MR1-dependent activation of MAIT 
cells. European journal of immunology 2016. 
 
97. Meierovics AI, Cowley SC. MAIT cells promote inflammatory monocyte differentiation into 
dendritic cells during pulmonary intracellular infection. The Journal of experimental 
medicine 2016; 213(12): 2793-2809. 
 
98. Booth JS, Salerno-Goncalves R, Blanchard TG, Patil SA, Kader HA, Safta AM et al. 
Mucosal-Associated Invariant T Cells in the Human Gastric Mucosa and Blood: Role in 
Helicobacter pylori Infection. Frontiers in immunology 2015; 6: 466. 
2018 ICB Special Feature Review – MAIT cells 
 
99. Sharma PK, Wong EB, Napier RJ, Bishai WR, Ndung'u T, Kasprowicz VO et al. High 
expression of CD26 accurately identifies human bacteria-reactive MR1-restricted MAIT 
cells. Immunology 2015; 145(3): 443-53. 
 
100. Gold MC, Eid T, Smyk-Pearson S, Eberling Y, Swarbrick GM, Langley SM et al. Human 
thymic MR1-restricted MAIT cells are innate pathogen-reactive effectors that adapt 
following thymic egress. Mucosal immunology 2013; 6(1): 35-44. 
 
101. Harriff MJ, Cansler ME, Toren KG, Canfield ET, Kwak S, Gold MC et al. Human lung 
epithelial cells contain Mycobacterium tuberculosis in a late endosomal vacuole and are 
efficiently recognized by CD8(+) T cells. PloS one 2014; 9(5): e97515. 
 
102. Jiang J, Yang B, An H, Wang X, Liu Y, Cao Z et al. Mucosal-associated invariant T cells 
from patients with tuberculosis exhibit impaired immune response. The Journal of infection 
2016; 72(3): 338-52. 
 
103. Salerno-Goncalves R, Luo D, Fresnay S, Magder L, Darton TC, Jones C et al. Challenge of 
Humans with Wild-type Salmonella enterica Serovar Typhi Elicits Changes in the Activation 
and Homing Characteristics of Mucosal-Associated Invariant T Cells. Frontiers in 
immunology 2017; 8: 398. 
 
104. Howson LJ, Napolitani G, Shepherd D, Ghadbane H, Kurupati P, Preciado-Llanes L et al. 
MAIT cell clonal expansion and TCR repertoire shaping in human volunteers challenged 
with Salmonella Paratyphi A. Nature communications 2018; 9(1): 253. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2018 ICB Special Feature Review – MAIT cells 
Table 1a 
 
Microbes that activate 
MAIT cells 
Expansion or 
activation in 
vitro (and 
MR1 
dependency) 
Expansion or 
activation in 
vivo 
Riboflavin 
pathway 
based on 
KEGG 
pathway 
database (and 
knock-outs) 
Reference 
Bacteroides 
thetaiotaomicron 
ND X X 21 
Bifidobacterium animalis ND X No* 21 
Candida albicans X(X) X X 21, 58, 60, 72 
Candida glabrata X(X) ND X 21 
Corynebacterium striatum X(X) ND X 73 
Escherichia coli X (X) X† X(X) 4, 13, 21, 27, 39, 49, 59, 72-96 
Enterobacter cloacae ND X X 21 
Francisella tularensis X(X) X†† X 63, 97 
Helicobacter pylori X(X) X†† X 75, 98 
Klebsiella pneumoniae X(X) X X 21, 27, 62, 73, 93 
Lactobacillus acidophilus X X No* 21 
Lactobacillus casei ND X No* 21 
Lactococcus lactis X(X) ND X(X) 39 
Mycobacterium abscessus X(X) X X 21 
Mycobacterium avium X ND X 60 
Mycobacterium bovis X(X) X† X 13, 64, 80 
Mycobacterium smegmatis X(X) ND X 58, 60, 99 
Mycobacterium 
tuberculosis 
X(X) ND X 2, 60, 80, 100-102 
Neisseria gonorrhoeae X ND X 60 
Nocardia asteroides X ND X** 60 
Pseudomonas aeruginosa X (X) X X 18, 21, 27, 60, 73, 81, 93 
Saccharomyces cerevisiae X(X) ND X 21 
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Salmonella enterica serovar 
Typhimurium 
X(X) X†† X(X) 2, 5, 19, 27, 30, 39, 58, 60, 86, 91, 93, 103 
Salmonella enterica serovar  
Paratyphi A 
X(X) X X 104 
Shigella flexneri X(X) ND X 60, 86 
Staphylococcus aureus X X X 2, 4, 21, 60, 73 
Staphylococcus epidermidis X(X) X X 21, 27 
Streptococcus pneumoniae X(X) X X 43, 44 
Streptococcus pyogenes X(X) ND No 60 
Vibrio parahemoliticus X ND X 60 
Yersinia enterocolitica X ND X 60 
 
 
*Intact KEGG riboflavin synthesis pathways have not been documented in the strains tested to date. 
**Species not listed in the KEGG pathway database but other species of the same genus feature the 
riboflavin pathway.  
†Mild MAIT cell accumulation in vivo. 
 ††Strong MAIT cell accumulation in vivo. 
ND No data available. 
 
 
 
Table 1b 
 
Microbes that do not activate 
MAIT cells 
Reference 
Streptococcus group A 21 
Enterococcus faecalis  21, 39, 60, 73, 81, 95, 96 
Listeria monocytogenes 2, 4, 73, 91 
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